Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor

Equality Impact Assessment (Guidance development) (PDF 179 KB)

Final appraisal determination

Committee papers (PDF 1.34 MB)

Committee papers Committee presentation (PDF 287 KB)

Final appraisal determination document (PDF 343 KB)

Draft guidance

Appraisal consultation document (PDF 299 KB)

Committee papers (PDF 8.72 MB)

Committee papers Committee meeting presentation (PDF 493 KB)

Final scope (PDF 121 KB)

Final matrix (PDF 38 KB)

NICE's response to comments on the draft scope and provisional matrix (PDF 332 KB)

Equality Impact Assessment (Guidance development) (PDF 180 KB)

Draft scope for consultation (pre-referral) January 2015 (PDF 127 KB)

Provisional matrix (pre-referral) January 2015 (PDF 39 KB)